Sharda Cropchem Ltd. · NSE:SHARDACROP

Sharda Cropchem — Q2 FY24 Earnings Presentation

35 slides from Sharda Cropchem's earnings presentation, Oct 21, 2023

  1. Slide 1: Stock exchange submission letter for investor presentation

    VW2FWREHU 7R 1DWLRQDO 6WRFN ([FKDQJH RI ,QGLD %6(/LPLWHG /LPLWHG 3KLUR]H-HHMHHEKRL7RZHU ([FKDQJH3OD]DWK)ORRU3ORW1R 'DODO6WUHHW & 0XPEDL± *%ORFN%DQGUD.XUOD&RPSOH[ %DQGUD ( 0XPEDL± 7UDGLQJ6\PERO6+$5'$&523 6FULS&RGH 6XEMHFW,QYHVWRUV$QDO\VW¶V3UHVHQWDWLRQIRUWKH4XDUWHUDQGKDOI\HDUHQGHG WK6HSWHPEHU 'HDU6LU0

  2. Slide 2: Investor Presentation October 2023

    Investor Presentation October 2023

  3. Slide 3: Safe Harbor

    Safe Harbor This presentation and the accompanying slides (the “Presentation”), which have been prepared by Sharda Cropchem Limited (the “Company”), have been prepared solely for information purposes and do not constitute any offer, recommendation or invitation to purchase or subscribe for any secur

  4. Slide 4: About Sharda Cropchem Limited

    About Sharda Cropchem Limited

  5. Slide 5: Fast-growing global agrochemicals company

    “We are a fast-growing global agrochemicals company with a peer position in the generic crop protection chemicals industry. Our vast and growing library of dossiers and IPRs provide us solid foundations for growth in the global marketplace, especially in Advanced Markets such as Europe, North Americ

  6. Slide 6: Agrochemical Focused Company

    Agrochemical Focused Company Intellectual Property (IP) driven company engaged in marketing and distribution of wide range formulations and generic active ingredients Efficiently channelizing time and resources for strengthening core Asset Light Business Model competency of identifying generic molec

  7. Slide 7: Asset Light Business Model

    Asset Light Business Model Overall Agrochemical Value Chain Sharda’s Operating Area ξ ξ ξ ξ Basic & Applied Active Ingredient Formulation & Marketing & Identification Registration Manufacturing Research Packaging Distribution SHARDA CROPCHEM’s ASSET LIGHT BUSINESS MODEL Focus on identification of ge

  8. Slide 8: 80+ countries: Increasing Global Presence

    Increasing Global Presence having a Widespread Distribution Over the years, we’ve built a strong brand Presence franchise within our global markets; we are benefiting through the economies of scale in 80+ countries our portfolio and leveraging value of our across Europe, NAFTA, supply chain to deliv

  9. Slide 9: The Sharda Advantage

    The Sharda Advantage THE SHARDA ADVANTAGE One Stop Healthy Solution Wide Product Quality with Faster Sales Global Reach relationships Provider for Range Affordability Service with suppliers Crop Care Products 8

  10. Slide 10: Way Forward

    Way Forward Forward Integration - Build Sales Force Expand & Strengthen Distribution Presence ¾ Leverage market presence and execution capabilities ¾ Expand geographical reach using existing library of dossiers ¾ Adopt the factory to farmer approach and be a one stop solution provider ¾ Two-fold str

  11. Slide 11: Industry Outlook and Growth Drivers

    Industry Outlook and Growth Drivers Global crop protection chemicals market value (In Billion USD) – CAGR of 3.5% 59.7 62.8 77.0 53.0 42.0 43.7 8.1 8.4 10.2 7.7 5.3 3.9 5.9 4.3 5.4 0.5 0.6 0.8 2020 2025e 2030e Herbicide Fungicide Insecticide Nematicide Molluscicide INDUSTRY DRIVERS 1 2 3 Fewer arabl

  12. Slide 12: Experienced Management

    Experienced Management Mr. Ramprakash M R k h V. V Bubna B b Mr. Ashish M A hi h Bubna B b Mr. Manish Bubna Mr Chairman & Managing Director Whole Time Director Whole Time Director • Holds a Bachelor’s Degree of • Holds a Bachelor’s Degree in Commerce from • Holds a Bachelor’s Degree in Chemical Tech

  13. Slide 13: Q2 FY24 Financial Highlights

    Q2 FY24 Financial Highlights

  14. Slide 14: Q2 FY24: Segment Wise Highlights

    Q2 FY24: Segment Wise Highlights Cr. Agrochemical Segment Non-Agrochemical Segment TOTAL REVENUES 80% 76% 20% 24% % of Revenue 100% 100% 576 146 140 722 441 581 Q2FY23 Q2FY24 Q2FY23 Q2FY24 Q2FY23 Q2FY24 -23% -4% -20% On Consolidated Basis 13

  15. Slide 15: Q2 FY24: Product Wise Highlights (Agrochemical Segment)

    Q2 FY24: Product Wise Highlights (Agrochemical Segment) Cr. Herbicides Insecticides Fungicides TOTAL REVENUES (Agrochemical Segment) 56% 55% 22% 29% 22% 16% % of Revenue 100% 100% 322 125 130 129 576 242 441 69 Q2FY23 Q2FY24 Q2FY23 Q2FY24 Q2FY23 Q2FY24 Q2FY23 Q2FY24 -25% +4% -47% -23% On Consolidate

  16. Slide 16: Q2 FY24: Region Wise Breakup (Agrochemical Segment)

    Q2 FY24: Region Wise Breakup (Agrochemical Segment) Cr. Europe NAFTA Region TOTAL REVENUES (Agrochemical Segment) 41% 53% 40% 30% -3% -42% 576 239 231 230 133 441 Q2FY23 Q2FY24 Q2FY23 Q2FY24 LATAM Region RoW 11% 11% 8% 6% Q2FY23 Q2FY24 -21% -40% 63 44 50 27 -23% Q2FY23 Q2FY24 Q2FY23 Q2FY24 % of Reve

  17. Slide 17: Q2 FY24: Region Wise Breakup (Non Agrochemical Segment)

    Q2 FY24: Region Wise Breakup (Non Agrochemical Segment) Cr. Europe NAFTA Region TOTAL REVENUES (Non - Agrochemical Segment) 22% 16% 57% 61% +3% -29% 146 32 86 140 83 23 Q2FY23 Q2FY24 Q2FY23 Q2FY24 LATAM Region RoW 7% 6% 14% 17% Q2FY23 Q2FY24 +13% -20% 10 23 8 21 -4% Q2FY23 Q2FY24 Q2FY23 Q2FY24 % of

  18. Slide 18: Q2 FY24: Financial Highlights

    Q2 FY24: Financial Highlights Cr. Revenues & GP Margin EBITDA Profit After Tax 27.3% 25.1% Increased other expenses 105 are related to strengthening of global workforce to 12 support future growth 722 581 38 Q2FY23 Q2FY24 Q2FY23 Q2FY24 -28 Q2FY23 Q2FY24 • Gross Margins reduced to 25.1% in Q2 FY24 •

  19. Slide 19: H1 FY24 Financial Highlights

    H1 FY24 Financial Highlights

  20. Slide 20: H1 FY24 Segment Wise Highlights

    H1 FY24 Segment Wise Highlights Cr. Agrochemical Segment Non Agrochemical Segment TOTAL REVENUES 77% 75% 23% 25% % of Revenue 100% 100% 1,190 356 1,546 303 916 1,219 H1FY23 H1FY24 H1FY23 H1FY24 H1FY23 H1FY24 -23% -15% -21% On Consolidated Basis 19

  21. Slide 21: H1 FY24: Product Wise Highlights (Agrochemical Segment)

    H1 FY24: Product Wise Highlights (Agrochemical Segment) Cr. Herbicides Insecticides Fungicides TOTAL REVENUES (Agrochemical Segment) 57% 54% 19% 25% 24% 21% % of Revenue 100% 100% 674 230 229 286 1,190 494 916 193 H1FY23 H1FY24 H1FY23 H1FY24 H1FY23 H1FY24 H1FY23 H1FY24 -27% -1% -33% -23% On Consolid

  22. Slide 22: H1 FY24: Region Wise Breakup (Agrochemical Segment)

    H1 FY24: Region Wise Breakup (Agrochemical Segment) Cr. Europe NAFTA Region TOTAL REVENUES (Agrochemical Segment) 46% 52% 35% 33% -13% -29% 1,190 551 422 477 299 916 H1FY23 H1FY24 H1FY23 H1FY24 LATAM Region RoW 12% 10% 6% 5% H1FY23 H1FY24 -38% -31% 146 71 90 50 -23% H1FY23 H1FY24 H1FY23 H1FY24 % of

  23. Slide 23: H1 FY24: Region Wise Breakup (Non Agrochemical Segment)

    H1 FY24: Region Wise Breakup (Non Agrochemical Segment) Cr. Europe NAFTA Region TOTAL REVENUES (Non - Agrochemical Segment) 26% 15% 56% 56% -51% -14% 356 91 198 171 303 44 H1FY23 H1FY24 H1FY23 H1FY24 LATAM Region RoW 6% 6% 12% 23% H1FY23 H1FY24 -18% +56% 23 69 19 44 -15% H1FY23 H1FY24 H1FY23 H1FY24

  24. Slide 24: H1 FY24: Financial Highlights

    H1 FY24: Financial Highlights Cr. Revenues & GP Margin EBITDA Profit After Tax 26.3% 16.5% Increased other expenses 204 are related to strengthening of global workforce to 35 1,546 1 546 support future growth 1,219 H1FY23 H1FY24 -28 -116 H1FY23 H1FY24 H1FY23 H1FY24 • Gross Margins reduced to 16.5% i

  25. Slide 25: Strong Balance Sheet

    Strong Balance Sheet Working Capital (in Days) RoCE RoE 25.7% 19.8% 91 days 120 days 20.8% 16.5% 97 93 86 74 Mar-22 Mar-23 Mar-22 Mar-23 70 70 Cash & Cash Total Debt Total Equity Equivalents Sep-22 Sep-23 Rs. 2,089 Rs. 311 Rs. 2 crores crores crores* Inventory Days Recievable Days Creditor Days Rs.

  26. Slide 26: Annexure

    Annexure

  27. Slide 27: Q2 & H1 FY24 Financial Highlights

    Q2 & H1 FY24 Financial Highlights Cr. Particulars Q2 FY24 Q2 FY23 Y-o-Y H1 FY24 H1 FY23 Y-o-Y Revenue from Operations 580.8 721.5 -20% 1,218.5 1,546.0 -21% COGS 435.2 524.4 1,017.3 1,139.5 Gross Profit 145.6 197.1 -26% 201.2 406.5 -50% Gross Margin % 25.1% 27.3% 16.5% 26.3% Employee Expenses 9.2 8.6

  28. Slide 28: Balance Sheet

    Balance Sheet Cr. EQUITY & LIABILITIES Sep-23 Mar-23 ASSETS Sep-23 Mar-23 Equity Non-current assets Equity share capital 90.2 90.2 Other equity 1,998.4 2,141.8 Property, plant and equipment 22.0 5.0 Equity attributable to equity holders of the Company 2,088.6 2,232.0 Goodwill 0.0 0.0 Non-controlling

  29. Slide 29: Cash Flow Statement

    Cash Flow Statement Particulars (Rs. Cr.) H1 FY24 H1 FY23 Profit Before Tax -138.7 32.2 Adjustments 124.9 135.9 Operating profit before working capital changes -13.7 168.1 Changes in working capital 222.0 18.1 Cash generated from operations 208.2 186.2 Direct taxes paid (net of refund) -38.5 -14.9 N

  30. Slide 30: Key Financial Performance Indices

    Key Financial Performance Indices Cr. Revenue EBITDA & EBITDA Margin* Profit After Tax & PAT Margin 20.7% 18.5% 17.6% 19.0% 17.6% 11.2% 8.8% 8.2% 9.8% 8.5% 4,045 3,580 729 713 349 342 2,396 1,998 2,003 455 229 369 352 176 165 FY19 FY20 FY21 FY22 FY23 FY19 FY20 FY21 FY22 FY23 FY19 FY20 FY21 FY22 FY23

  31. Slide 31: Historical Profit & Loss

    Historical Profit & Loss Cr. Particulars FY23 FY22 FY21 FY20 FY19 Revenue from Operations 4,045.2 3,579.8 2,395.6 2,003.0 1,997.6 COGS 2,860.8 2,499.8 1,636.0 1,388.8 1,387.3 Gross Profit 1,184.4 1,080.0 759.7 614.3 610.2 Gross Margin % 29.3% 30.2% 31.7% 30.7% 30.5% Employee Expenses 44.8 44.2 37.3

  32. Slide 32: Balance Sheet – Equity & Liabilities

    Balance Sheet – Equity & Liabilities Cr. Equities & Liabilities FY23 FY22 FY21 FY20 FY19 Shareholder's Funds Equity and Share Capital 90.2 90.2 90.2 90.2 90.2 Other Equity 2141.8 1,822.2 1,524.1 1,312.6 1,193.7 Non-controlling Interest 0.4 0.3 0.3 0.3 0.2 Total Equity 2,232.4 1,912.8 1,614.6 1,403.1

  33. Slide 33: Balance Sheet - Assets

    Balance Sheet - Assets Cr. ASSETS FY23 FY22 FY21 FY20 FY19 Assets Non-Current Assets Property, Plant and Equipment 5.0 14.4 20.9 27.8 13.5 Goodwill 0.0 0.0 0.4 0.4 0.4 Other Intangible assets 663.0 577.4 523.1 388.1 357.8 Intangible assets under development 203.9 212.2 131.0 161.4 219.8 Deferred Tax

  34. Slide 34: CSR Activities

    CSR Activities CSR initiatives taken up by the Company are in the areas of Promoting Education, Healthcare, Eradicating Hunger, Empowerment of Women, Animal Welfare, Promotion of Sports and Rural Development Projects Promoting Education Animal Welfare Medical Aid & Relief 33

  35. Slide 35: Thank You

    THANK YOU Company: y Sharda Cropchem p Limited Investor Relation Advisors: Strategic Growth Advisors Pvt. Ltd. CIN: L51909MH2004PLC145007 CIN: U74140MH2010PTC204285 Mr. Dinesh Nahar – General Manager - Finance Mr. Deven Dhruva finance@shardaintl.com deven.dhruva@sgapl.net Tel: +91 22 6678 2800 Tel:

Sharda Cropchem — Q2 FY24 Earnings Presentation on 6ix